Skip to main content

Multi—Disciplinary Treatment for Lung Cancer: Prospects for Increased Cure Rates in the Next Decade

  • Chapter
Drugs and the Lung

Part of the book series: Ettore Majorana International Science Series ((EMISS,volume 14))

  • 69 Accesses

Abstract

The overall cure rate in lung cancers has not improved·for several decades in spite of the most expert surgery and radiation therapy (1,2). This is because most patients with apparently localised tumours have disseminated micrometastases at presentation. These metastases cannot be detected by current diagnostic techniques. The relationship between our ability to detect tumours in relation to their biological development and the death of the host is illustrated diagramatically in Figure 1.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Silverberg, E. 1981. Cancer Statistics, American Cancer Society Professional Education Publications.

    Google Scholar 

  2. Cancer Statistics Surviva. 1980. Office of Population Cencuses and Surveys. Series M.B.I. No. 3. London. Her Majesty’s Stationery Office.

    Google Scholar 

  3. Goldie, J. H. and Coldman, A. J. (1979). A mathematical model for relating the drug sensitivity of tumours to their spontaneous mutation rate. Cancer Treat. Rep., 63, 1727.

    Google Scholar 

  4. Skipper, H. E., Schabel, F. M.Jr., & Wilcox, W. S. 1964. Experimental evaluation of potential anticancer agents. XIII. On the criterial and kinetics associated with the ‘curability’ of experimental leukaemia. Cancer Chemother. Rep., 35, 1.

    Google Scholar 

  5. Bruce, W. R., Meeker, B. E. and Valeriote, F. A. 1966. Comparison of the sensitivity of normal haematopoetic and transplanted lymphoma colony-forming cells to chemo-therapeutic agents administered in vivo. J. Natl. Cancer Inst. 37, 233.

    Google Scholar 

  6. Cooper, R. G., Holland, J. F. & Glidewell, O. 1979. Adjuvant chermotherapy of breast cancer. Cancer, 44, 793.

    Article  Google Scholar 

  7. Bonadonna, G. and Valagussa, P. 1981. Dose-response effect of adjuvant chemotherapy in breast cancer 1980. New Eng. J. Med., 304, 10.

    Article  Google Scholar 

  8. Price, L. A. and Hill, Bridget T. 1982. Safe and effective 24 hour combination chemotherapy without cis-platin as initial treatment in Head and Neck Cancer: Improved Survival at 5 years. Proceedings of Eighteenth Annual Meeting of the American Society of Clinical Oncology, St. Louis, C786, p 202.

    Google Scholar 

  9. Livingston, R. B. and Greenstreet, R. L. 1982. Reinduction prolongs survival in complete responders with small cell lung cancer. Proceedings of the Eighteenth Annual Meeting of the American Society of Clinical Oncology, St. Louis. C588, p.151.

    Google Scholar 

  10. Weick, J. K., Joseph, D., Purvis, M. D. & Livingston, R.B. 1982. Divided dose Mitomycin C and Vinblastine in Extensive Non-small Cell Lung Carcinoma. Proceedings Eighteenth Annual Meeting of the American Society of Clinical Oncology, St. Louis. C588, p.151.

    Google Scholar 

  11. Price, L. A. 1973. A kinetic approach to the drug treatment of solid tumours. In: The Third Vinca Alkaloids Symposium Ed. Shedden.

    Google Scholar 

  12. Price, L. A. & Goldie, J.H. 1971. Twenty-four hour combination chemotherapy for disseminated malignant disease. Brit. Med. J., 4, 336.

    Article  Google Scholar 

  13. Hill, Bridget T. & Price, L.A. 1982. An experimental biological basis for increaseing the therapeutic index of clinical cancer chemotherapy. Annals of the New York Academy of Sciences.

    Google Scholar 

  14. Symposium on ‘Safer Cancer Chemotherapy’. Royal College of Surgeons of England. 1981. Eds: Price, L.A., Hill, Bridget T. & Ghilchik, M.W. Publ. Bailliere Tindall.

    Google Scholar 

  15. Tate, H.C., Rawlinson, J.B. & Freedman, L.S. 1979. Lancet, 2, 623.

    Article  Google Scholar 

  16. Hill, Bridget T. 1980. Principles of Tumour Growth. In: Scientific Foundations of Respiratory Medicine. Eds: Scadding, J. G. & Cumming, G. p.593.

    Google Scholar 

  17. Price, L. A. 1980 Principles of Tumour Growth. In: Scientific Foundations of Respiratory Med icine. Eds. Scadding, J. G. & Cumming, G. p.603.

    Google Scholar 

  18. Carter, S. K. & Soper, W. T. 1974. Cancer Treatment Reviews, 1, p.l.

    Google Scholar 

  19. Hill, B. T. & Price, L. A. 1977. Concepts and Prospects in Adjuvant Chemotherapy. In: ’Secondary Spread in Breast Cancer’; Vol. 3. New Aspects of Breast Cancer, p. 193. Ed: Stoll Heinemann Medical, London.

    Google Scholar 

  20. Price, L. A. & Hill, Bridget, T. 1974. Classification of anti-tumour drugs. Lancet, ii, 172.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer Science+Business Media New York

About this chapter

Cite this chapter

Price, L.A., Hill, B.T. (1984). Multi—Disciplinary Treatment for Lung Cancer: Prospects for Increased Cure Rates in the Next Decade. In: Cumming, G., Bonsignore, G. (eds) Drugs and the Lung. Ettore Majorana International Science Series, vol 14. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1269-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-1269-8_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-1271-1

  • Online ISBN: 978-1-4757-1269-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics